You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Discontinued ProductD-Cycloserine (Cat. No. 0465) has been withdrawn from sale for commercial reasons.
Biological Activity for D-Cycloserine
Partial agonist at the glycine-NMDA site. Counters amnesia in animals and man.
Technical Data for D-Cycloserine
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets for D-Cycloserine
References for D-Cycloserine
References are publications that support the biological activity of the product.
Chessell et al (1991) D-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-MthD.-aspartate receptor ionophore complex in Alzheimer brain. Brain Res. 565 345 PMID: 1842701
Flood et al (1992) Effect on memory processing by D-cycloserine, an agonist of the NMDA glycine receptor. Eur.J.Pharmacol. 221 249 PMID: 1330624
Kawabe et al (1998) Intrahippocampal D-cycloserine improves MK-801-induced memory deficits: radial-arm maze performace in rats. Brain Res. 814 226 PMID: 9838131
Watson et al (1990) D-Cycloserine acts as a partial agonist at the glycine site of the NMDA receptor expressed in Xenopus oocytes. Brain Res. 510 158 PMID: 2157524
View Related Products by Product Action
Keywords: D-Cycloserine, D-Cycloserine supplier, NMDA, Receptors, 0465, Tocris Bioscience
Citations for D-Cycloserine
Citations are publications that use Tocris products.
Currently there are no citations for D-Cycloserine.
Reviews for D-Cycloserine
There are currently no reviews for this product. Be the first to review D-Cycloserine and earn rewards!
Have you used D-Cycloserine?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Huntington's Disease Research Product Guide
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:
- Somatic Instability
- Proteolysis and Inclusion Bodies
- Transcriptional Dysregulation
- Mitochondrial Dysfunction
- Nuclear-Cytoplasmic Transport Interference
- Stem Cells
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Huntington's Disease Poster
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Learning & Memory Poster
Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.